查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1282918

临床试验管理软件市场-全球市场规模、份额、趋势分析、机会、预测报告，2019-2029，按产品；按交付模式；按部署模式；按最终用途；

Clinical Trial Management Software Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Delivery Mode ; By Deployment Mode ; By End Use ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球临床试验管理软件 (CTMS) 市场将在 2029 年扩大 2.5 倍以上，超过 26 亿美元

由于临床试验的复杂性不断增加、海量数据的生成以及 CTMS 中人工智能等现代技术的采用，全球临床试验管理软件 (CTMS) 市场正在获得越来越多的关注。

战略咨询和市场研究领导者 BlueWeave Consulting 最近估计，2022 年全球临床试验管理软件 (CTMS) 市场价值将达到 10.3278 亿美元。 在2023-2029年预测期内，全球临床试验管理软件（CTMS）市场规模预计将以14.55%的复合年增长率增长，到2029年达到26.5643亿美元。 临床试验管理软件（CTMS）市场的关键增长因素包括产学界合作的加强、临床试验数量的增加、医疗保健技术的开拓以及政府对研究试验的补贴增加。 此外，慢性病发病率上升等变量与临床试验管理系统 (CTMS) 数量的增加有关。

本报告的详细分析提供了有关增长潜力、未来趋势和全球临床试验管理软件 (CTMS) 市场的信息。 它还涵盖了推动市场总规模预测的因素。 该报告致力于提供全球临床试验管理软件（CTMS）市场的最新技术发展和行业见解，帮助决策者做出明智的战略决策。 它还分析了市场的增长动力、挑战和竞争动态。

内容

第一章研究框架

第 2 章执行摘要

第 3 章全球临床试验管理软件 (CTMS) 市场洞察

  • 行业价值链分析
  • DROC 分析
    • 增长动力
      • 需要有效管理临床试验数据和工作流程
      • 临床试验的复杂性和生成的大量数据
      • 在CTMS中引入人工智能等创新技术
    • 制约因素
      • 安装和维护成本高
      • 数据隐私和安□□全问题
    • 机会
      • 个性化医疗需求不断增长
      • 对罕见疾病的关注日益增加
    • 任务
      • 确保基于云的临床试验管理软件 (CTMS) 系统中的数据隐私和安□□全
  • 技术进步/最新发展
  • 监管框架
  • 波特五力分析

第 4 章全球临床试验管理软件 (CTMS) 市场概述

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品
      • 软件
      • 服务
    • 通过交付
      • 网络託管
      • 本地
      • 基于云
    • 按部署模式
      • 公司
      • 现场
    • 按最终用途
      • 医药
      • 医疗器械製造商
      • 合同研究组织
      • 其他
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第 5 章：北美临床试验管理软件 (CTMS) 市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品
    • 通过交付
    • 按部署模式
    • 按最终用途
    • 按国家/地区
      • 美国
      • 加拿大

第 6 章：欧洲临床试验管理软件 (CTMS) 市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品
    • 通过交付
    • 按部署模式
    • 按最终用途
    • 按国家/地区
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 欧洲其他地区

第七章亚太临床试验管理软件 (CTMS) 市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品
    • 通过交付
    • 按部署模式
    • 按最终用途
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印度尼西亚
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区的其他国家/地区

第 8 章：拉丁美洲的临床试验管理软件 (CTMS) 市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品
    • 通过交付
    • 按部署模式
    • 按最终用途
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其余拉丁美洲地区

第 9 章中东和非洲临床试验管理软件 (CTMS) 市场

  • 2019-2029 年市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按产品
    • 通过交付
    • 按部署模式
    • 按最终用途
    • 按国家/地区
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • 多边环境协定的其余部分

第 10 章竞争格局

  • 主要公司及其产品列表
  • 2022 年全球临床试验管理软件 (CTMS) 市场份额分析
  • 通过运行参数进行竞争基准测试
  • 重大战略发展（合併、收购、合作伙伴关係等）

第 11 章 COVID-19 对全球临床试验管理软件 (CTMS) 市场的影响

第十二章公司简介（公司简介、财务矩阵、竞争格局、关键人才、主要竞争对手、联繫地址、战略展望、SWOT 分析）

  • Oracle Corporation
  • Medidata Solutions（a Dassault Systemes Company）
  • Parexel International Corporation
  • BioClinica, Inc.
  • PRA Health Sciences, Inc.
  • ArisGlobal LLC
  • Veeva Systems Inc.
  • MedNet Solutions, Inc.
  • Forte Research Systems, Inc.
  • eClinForce, Inc.
  • DSG, Inc.
  • Data MATRIX Corp.
  • Merge Healthcare Incorporated
  • DATATRAK International, Inc.
  • MasterControl, Inc.
  • Other Prominent Players

第 13 章关键战略建议

第 14 章研究方法

  • 定性研究
    • 初级和次级研究
  • 定量研究
  • 市场细分和数据三角测量
    • 二次调查
    • 初步调查
  • 主要调查受访者按地区细分
  • 假设和限制
简介目录
Product Code: BWC23421

Global Clinical Trial Management Software (CTMS) Market Size Zooming More Than 2.5X to Cross USD 2.6 Billion by 2029

The global clinical trial management software (CTMS) market is gaining traction because of the increasing complexity of clinical trials and the huge amount of data generated and adoption of modern technologies, such as artificial intelligence, in CTMS.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global clinical trial management software (CTMS) market size at USD 1,032.78 million in 2022. During the forecast period between 2023 and 2029, the global clinical trial management software (CTMS) market size is projected to grow at an impressive CAGR of 14.55% reaching a value of USD 2,656.43 million by 2029. Major growth factors for the global clinical trial management software (CTMS) market include the rise in industry-academic partnerships, the rise in clinical trials, the development of healthcare technology, and the expansion of government funding for research trials. Additionally, variables like the rising frequency of chronic diseases have been linked to the growth in the number of clinical trial management systems (CTMS).

Global Clinical Trial Management Software (CTMS) Market - Overview:

An enterprise software system called a clinical trial management system (CTMS) is used to coordinate and monitor clinical research operations within a facility. This system serves various purposes including giving easy access to a summary of a study's development with ongoing and current reporting, enabling research supervisors to schedule assignments and activities, assign roles, measure progress, arranging all of the data and papers pertinent to the study. A CTMS is used by research sites, site networks, health systems, academic medical centers, and cancer centers to centralize data on procedures, participants, staff, finances, and billing, among other things.

Global Clinical Trial Management Software (CTMS) Market - By Deployment Mode:

Based on deployment Mode, the global clinical trial management system (CTMS) market is segmented into enterprise and on-site. Enterprise deployment holds the larger share of the global clinical trial management system (CTMS) market. The segment growth is mainly attributed to its versatility according to the needs of the researchers and other end users. The capabilities of the clinical trial administration system include documents, spreadsheets, payments, contacts, and others. Enterprise-based clinical trial management software provides SMEs and large enterprises with a range of scaling options.

Impact of COVID-19 on the Global Clinical Trial Management Software (CTMS) Market

The global clinical trial management system (CTMS) market witnessed robust growth over the COVID-19 outbreak period. According to a report published on the National Center for Biotechnology Information, the management of clinical studies was adversely affected by the COVID-19 pandemic, which could jeopardize the validity of the data and cause patient safety concerns. It increased the need for efficient management systems, which not only help with the management of ongoing and delayed clinical trial data but also efficiently manage and improve access to clinical trials on the novel corona virus vaccine development.

Competitive Landscape:

Major players operating in the global clinical trial management system (CTMS) market include: Oracle Corporation, Medidata Solutions (a Dassault Systemes Company), Parexel International Corporation, BioClinica, Inc., PRA Health Sciences, Inc., ArisGlobal LLC, Veeva Systems Inc., MedNet Solutions, Inc., Forte Research Systems, Inc., eClinForce, Inc., DSG, Inc., Data MATRIX Corp., Merge Healthcare Incorporated, DATATRAK International, Inc., and MasterControl, Inc.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Clinical Trial Management Software (CTMS) market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Clinical Trial Management Software (CTMS) market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Clinical Trial Management Software (CTMS) Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Need for efficient management of trial data and workflows
      • 3.2.1.2. Increasing complexity of clinical trials and the huge amount of data generated
      • 3.2.1.3. The adoption of innovative technologies such as artificial intelligence in CTMS
    • 3.2.2. Restraints
      • 3.2.2.1. High implementation and maintenance costs
      • 3.2.2.2. Data privacy and security concerns
    • 3.2.3. Opportunities
      • 3.2.3.1. Growing demand for personalized medicine
      • 3.2.3.2. Increasing focus on rare diseases
    • 3.2.4. Challenges
      • 3.2.4.1. Ensuring data privacy and security in cloud-based Clinical Trial Management Software (CTMS) systems
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Clinical Trial Management Software (CTMS) Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Software
      • 4.2.1.2. Services
    • 4.2.2. By Delivery
      • 4.2.2.1. Web-hosted
      • 4.2.2.2. On-premises
      • 4.2.2.3. Cloud-based
    • 4.2.3. By Deployment Mode
      • 4.2.3.1. Enterprise
      • 4.2.3.2. On-site
    • 4.2.4. By End Use
      • 4.2.4.1. Pharma
      • 4.2.4.2. Medical Device Manufacturers
      • 4.2.4.3. CROs
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America (LATAM)
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Clinical Trial Management Software (CTMS) Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Delivery
    • 5.2.3. By Deployment Mode
    • 5.2.4. By End Use
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Product
      • 5.2.5.1.2. By Delivery
      • 5.2.5.1.3. By Deployment Mode
      • 5.2.5.1.4. By End Use
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Product
      • 5.2.5.2.2. By Delivery
      • 5.2.5.2.3. By Deployment Mode
      • 5.2.5.2.4. By End Use

6. Europe Clinical Trial Management Software (CTMS) Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Delivery
    • 6.2.3. By Deployment Mode
    • 6.2.4. By End Use
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Product
      • 6.2.5.1.2. By Delivery
      • 6.2.5.1.3. By Deployment Mode
      • 6.2.5.1.4. By End Use
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Product
      • 6.2.5.2.2. By Delivery
      • 6.2.5.2.3. By Deployment Mode
      • 6.2.5.2.4. By End Use
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Product
      • 6.2.5.3.2. By Delivery
      • 6.2.5.3.3. By Deployment Mode
      • 6.2.5.3.4. By End Use
      • 6.2.5.4. France
      • 6.2.5.4.1. By Product
      • 6.2.5.4.2. By Delivery
      • 6.2.5.4.3. By Deployment Mode
      • 6.2.5.4.4. By End Use
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Product
      • 6.2.5.5.2. By Delivery
      • 6.2.5.5.3. By Deployment Mode
      • 6.2.5.5.4. By End Use
      • 6.2.5.6. Belgium
      • 6.2.5.6.1. By Product
      • 6.2.5.6.2. By Delivery
      • 6.2.5.6.3. By Deployment Mode
      • 6.2.5.6.4. By End Use
      • 6.2.5.7. Russia
      • 6.2.5.7.1. By Product
      • 6.2.5.7.2. By Delivery
      • 6.2.5.7.3. By Deployment Mode
      • 6.2.5.7.4. By End Use
      • 6.2.5.8. The Netherlands
      • 6.2.5.8.1. By Product
      • 6.2.5.8.2. By Delivery
      • 6.2.5.8.3. By Deployment Mode
      • 6.2.5.8.4. By End Use
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Product
      • 6.2.5.9.2. By Delivery
      • 6.2.5.9.3. By Deployment Mode
      • 6.2.5.9.4. By End Use

7. Asia-Pacific Clinical Trial Management Software (CTMS) Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Delivery
    • 7.2.3. By Deployment Mode
    • 7.2.4. By End Use
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Product
      • 7.2.5.1.2. By Delivery
      • 7.2.5.1.3. By Deployment Mode
      • 7.2.5.1.4. By End Use
      • 7.2.5.2. India
      • 7.2.5.2.1. By Product
      • 7.2.5.2.2. By Delivery
      • 7.2.5.2.3. By Deployment Mode
      • 7.2.5.2.4. By End Use
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Product
      • 7.2.5.3.2. By Delivery
      • 7.2.5.3.3. By Deployment Mode
      • 7.2.5.3.4. By End Use
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Product
      • 7.2.5.4.2. By Delivery
      • 7.2.5.4.3. By Deployment Mode
      • 7.2.5.4.4. By End Use
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Product
      • 7.2.5.5.2. By Delivery
      • 7.2.5.5.3. By Deployment Mode
      • 7.2.5.5.4. By End Use
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Product
      • 7.2.5.6.2. By Delivery
      • 7.2.5.6.3. By Deployment Mode
      • 7.2.5.6.4. By End Use
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Product
      • 7.2.5.7.2. By Delivery
      • 7.2.5.7.3. By Deployment Mode
      • 7.2.5.7.4. By End Use
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Product
      • 7.2.5.8.2. By Delivery
      • 7.2.5.8.3. By Deployment Mode
      • 7.2.5.8.4. By End Use
      • 7.2.5.9. Vietnam
      • 7.2.5.9.1. By Product
      • 7.2.5.9.2. By Delivery
      • 7.2.5.9.3. By Deployment Mode
      • 7.2.5.9.4. By End Use
      • 7.2.5.10. Rest of APAC
      • 7.2.5.10.1. By Product
      • 7.2.5.10.2. By Delivery
      • 7.2.5.10.3. By Deployment Mode
      • 7.2.5.10.4. By End Use

8. Latin America Clinical Trial Management Software (CTMS) Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Delivery
    • 8.2.3. By Deployment Mode
    • 8.2.4. By End Use
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Product
      • 8.2.5.1.2. By Delivery
      • 8.2.5.1.3. By Deployment Mode
      • 8.2.5.1.4. By End Use
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Product
      • 8.2.5.2.2. By Delivery
      • 8.2.5.2.3. By Deployment Mode
      • 8.2.5.2.4. By End Use
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Product
      • 8.2.5.3.2. By Delivery
      • 8.2.5.3.3. By Deployment Mode
      • 8.2.5.3.4. By End Use
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Product
      • 8.2.5.4.2. By Delivery
      • 8.2.5.4.3. By Deployment Mode
      • 8.2.5.4.4. By End Use
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Product
      • 8.2.5.5.2. By Delivery
      • 8.2.5.5.3. By Deployment Mode
      • 8.2.5.5.4. By End Use

9. Middle East & Africa Clinical Trial Management Software (CTMS) Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Delivery
    • 9.2.3. By Deployment Mode
    • 9.2.4. By End Use
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Product
      • 9.2.5.1.2. By Delivery
      • 9.2.5.1.3. By Deployment Mode
      • 9.2.5.1.4. By End Use
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Product
      • 9.2.5.2.2. By Delivery
      • 9.2.5.2.3. By Deployment Mode
      • 9.2.5.2.4. By End Use
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Product
      • 9.2.5.3.2. By Delivery
      • 9.2.5.3.3. By Deployment Mode
      • 9.2.5.3.4. By End Use
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Product
      • 9.2.5.4.2. By Delivery
      • 9.2.5.4.3. By Deployment Mode
      • 9.2.5.4.4. By End Use
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Product
      • 9.2.5.5.2. By Delivery
      • 9.2.5.5.3. By Deployment Mode
      • 9.2.5.5.4. By End Use
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Product
      • 9.2.5.6.2. By Delivery
      • 9.2.5.6.3. By Deployment Mode
      • 9.2.5.6.4. By End Use
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Product
      • 9.2.5.7.2. By Delivery
      • 9.2.5.7.3. By Deployment Mode
      • 9.2.5.7.4. By End Use
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Product
      • 9.2.5.8.2. By Delivery
      • 9.2.5.8.3. By Deployment Mode
      • 9.2.5.8.4. By End Use

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Clinical Trial Management Software (CTMS) Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Clinical Trial Management Software (CTMS) Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Oracle Corporation
  • 12.2. Medidata Solutions (a Dassault Systemes Company)
  • 12.3. Parexel International Corporation
  • 12.4. BioClinica, Inc.
  • 12.5. PRA Health Sciences, Inc.
  • 12.6. ArisGlobal LLC
  • 12.7. Veeva Systems Inc.
  • 12.8. MedNet Solutions, Inc.
  • 12.9. Forte Research Systems, Inc.
  • 12.10. eClinForce, Inc.
  • 12.11. DSG, Inc.
  • 12.12. Data MATRIX Corp.
  • 12.13. Merge Healthcare Incorporated
  • 12.14. DATATRAK International, Inc.
  • 12.15. MasterControl, Inc.
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations